Innovating for a Healthier World
AbbVie is a global biopharmaceutical company dedicated to discovering and delivering innovative medicines for serious diseases. Founded in 2012, AbbVie has rapidly established itself as a leader in the pharmaceutical industry.
Key Areas of Focus
Immunology: AbbVie is known for its pioneering work in immunology, with a focus on autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
Oncology: The company offers a portfolio of treatments for various cancers, including hematologic malignancies and solid tumors.
Neurology: AbbVie develops medicines for neurological disorders, such as multiple sclerosis and migraine.
Vaccines: The company has a growing presence in the vaccines business, focusing on infectious diseases.
AbbVie’s goal is
Improving patient health: AbbVie’s focus on developing innovative medicines for serious diseases suggests a vision of improving patient outcomes and quality of life.
Advancing healthcare: AbbVie’s commitment to research and development indicates a desire to contribute to the advancement of healthcare through scientific breakthroughs.
Leading the industry: Given their position as a global leader in biopharmaceuticals, AbbVie’s vision likely includes maintaining their leadership position and driving innovation in the industry.
Notable Products
Some of AbbVie’s most well-known products include:
Humira: A blockbuster drug used to treat autoimmune diseases.
Rinvoq: A treatment for moderate to severe rheumatoid arthritis and psoriatic arthritis.
Skyrizi: A treatment for psoriasis and psoriatic arthritis.
Imbruvica: A treatment for chronic lymphocytic leukemia (CLL) and mantle cell lymphoma.
Recent Developments
AbbVie has been actively engaged in research and development, seeking to expand its product pipeline and address unmet medical needs. The company has also made significant investments in emerging technologies and partnerships to drive innovation.
